Multimodal endoscopic ultrasound diagnostic evaluation of pancreatic cystic lesions

Aim. To optimize the differential diagnosis of pancreatic cystic lesions by introducing novel endoscopic ultrasound (EUS) technologies into clinical practice.

Materials and Methods. The study analyzed the outcomes of multimodal diagnostic evaluation in 424 patients with pancreatic cystic lesions who underwent EUS.

Results. In 328 cases (77.4%), conventional B-mode EUS provided sufficient diagnostic information. In 96 cases (22.6%), contrast enhancement was required: 59 patients (61.5%) underwent assessment of contrast uptake by the cyst wall, septa, and solid components; 25 (26%) only by the wall and septa; and in 12 (12.5%) assessment was made ofnodular components of the pancreatic cystic lesions. Retrospective analysis demonstrated that contrast-enhanced EUS increased overall diagnostic accuracy for differentiating cystic neoplasms from post-necrotic pseudocysts by 14.7%, improved detection of solid components within cystic lesions by 11.3%, and enhanced identification of cystic adenocarcinomas or intraductal papillary mucinous neoplasms (IPMNs) associated with adenocarcinoma by 9.9%. The integration of contrast enhancement into the EUS diagnostic algorithm significantly reduced the number of fineneedle aspirations (FNA) required.

Conclusion. Both our clinical experience and data from international research underscore the necessity of incorporating multimodal EUS into the diagnostic work-up for cystic pancreatic lesions. Based on the study, an algorithm was developed for applying novel EUS technologies in the differential diagnosis of pancreatic cystic tumors.

1. Zerboni G., Signoretti M., Crippa S., Falconi M., Arcidiacono P.G., Capurso G. Systematic review and meta-analysis: prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals. Pancreatology. 2019; 19 (1): 2–9. https://doi.org/10.1016/j.pan.2018.11.014

2. Anonsen K., Sahakyan M.A., Kleive D., Waage A., Verbeke C., Hauge T., Buanes T., Edwin B., Labori K.J. Trends in manage ment and outcome of cystic pancreatic lesions – analysis of 322 cases undergoing surgical resection. Scand. J. Gastroenterol. 2019; 54 (8): 1051–1057. https://doi.org/10.1080/00365521.2019.1642379

3. Wesali S., Demir M.A., Verbeke C.S., Andersson M., Bratlie S.O., Sadik R. EUS is accurate in characterizing pancreatic cystic lesions; a prospective comparison with crosssectional imaging in resected cases. Surg. Endosc. 2021; 35 (12): 6650–6659. https://doi.org/10.1007/s00464-020-08166-3

4. Probst P., Hüttner F.J., Meydan Ö., Abu Hilal M., Adham M., Barreto S.G., Besselink M.G., Busch O.R., Bockhorn M., Del Chiaro M., Conlon K., Castillo C.F., Friess H., Fusai G.K., Gianotti L., Hackert T., Halloran C., Izbicki J., Kalkum E., Kelemen D., Kenngott H.G., Kretschmer R., Landré V., Lillemoe K.D., Miao Y., Marchegiani G., Mihaljevic A., Radenkovic D., Salvia R., Sandini M., Serrablo A., Shrikhande S., Shukla P.J., Siriwardena A.K., Strobel O., Uzunoglu F.G., Vollmer C., Weitz J., Wolfgang C.L., Zerbi A., Bassi C., Dervenis C., Neoptolemos J., Büchler M.W., Diener M.K. Evidence map of pancreatic surgery – a living systematic review with meta-analyses by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2021; 170 (5): 1517–1524. https://doi.org/10.1016/j.surg.2021.04.023.

5. Ohtsuka T., Fernandez-Del Castillo C., Furukawa T., Hijioka S., Jang J.Y., Lennon A.M., Miyasaka Y., Ohno E., Salvia R., Wolfgang C.L., Wood L.D. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024; 24 (2): 255–270. https://doi.org/10.1016/j.pan.2023.12.009

6. Al-Taee A.M., Taylor J.R. Endoscopic imaging of pancreatic cysts. Gastrointest. Endosc. Clin. N. Am. 2023; 33 (3): 583–598. https://doi.org/10.1016/j.giec.2023.03.005

7. Ohno E., Ishikawa T., Mizutani Y., Iida T., Uetsuki K., Yashika J., Yamada K., Gibo N., Aoki T., Kawashima H. Factors associated with misdiagnosis of preoperative endoscopic ultrasound in patients with pancreatic cystic neoplasms undergoing surgical resection. J. Med. Ultrason. (2001). 2022; 49 (3): 433–441. https://doi.org/10.1007/s10396-022-01205-7

8. Argüello L., Sánchez-Montes C., Mansilla-Vivar R., Artés J., Prieto M., Alonso-Lázaro N., Satorres-Paniagua C., PonsBeltrán V. Diagnostic yield of endoscopic ultrasound with fine-needle aspiration in pancreatic cystic lesions. Gastroenterol. Hepatol. 2020; 43 (1): 1–8. https://doi.org/10.1016/j.gastrohep.2019.07.012 (English, Spanish)

9. Fusaroli P., Serrani M., De Giorgio R., D'Ercole M.C., Ceroni L., Lisotti A., Caletti G. Contrast harmonic-endoscopic ultrasound is useful to identify neoplastic features of pancreatic cysts (with videos). Pancreas. 2016; 45 (2): 265–268. https://doi.org/10.1097/MPA.0000000000000441

10. Yamazaki T., Takenaka M., Omoto S., Yoshikawa T., Ishikawa R., Okamoto A., Nakai A., Minaga K., Kamata K., Yamao K., Komeda Y., Watanabe T., Nishida N., Kamei K., Matsumoto I., Takeyama Y., Chikugo T., Chiba Y., Kudo M. Should contrast-enhanced harmonic endoscopic ultrasound be incorporated into the International Consensus Guidelines to determine the appropriate treatment of intraductal papillary mucinous neoplasm? J. Clin. Med. 2021; 10 (9): 1818. https://doi.org/10.3390/jcm10091818

11. Karmazanovsky G.G., Stepanova Yu.A., Askerova N.N. History of Development of Contrast-Enhanced Imaging at Ultrasound. Medical Visualization. 2015; 2: 109–119. (In Russian)

12. Pitman M.B., Centeno B.A., Reid M.D., Siddiqui M.T., Layfield L.J., Perez-Machado M., Weynand B., Stelow E.B., Lozano M.D., Fukushima N., Cree I.A., Mehrotra R., Schmitt F.C., Field A.S. The World Health Organization Reporting System for Pancreaticobiliary Cytopathology. Acta Cytol. 2023; 67 (3): 304–320. https://doi.org/10.1159/000527912

13. Early D.S., Acosta R.D., Chandrasekhara V., Chathadi K.V., Decker G.A., Evans J.A., Fanelli R.D., Fisher D.A., Fonkalsrud L., Hwang J.H., Jue T.L., Khashab M.A., Lightdale J.R., Muthusamy V.R., Pasha S.F., Saltzman J.R., Sharaf R.N., Shergill A.K., Cash B.D. ASGE Standards of Practice Committee; Adverse events associated with EUS and EUS with FNA. Gastrointest. Endosc. 2013; 77 (6): 839–843. https://doi.org/10.1016/j.gie.2013.02.018

14. Kovacevic B., Klausen P., Rift C.V., Toxværd A., Grossjohann H., Karstensen J.G., Brink L., Hassan H., Kalaitzakis E., Storkholm J., Hansen C.P., Hasselby J.P., Vilmann P. Clinical impact of endoscopic ultrasound-guided through-the-needle microbiopsy in patients with pancreatic cysts. Endoscopy. 2021; 53 (1): 44–52. https://doi.org/10.1055/a-1214-6043

15. Kubyshkin V.А., Каrmazanovsky G.G., Grishankov S.А. Kistoznyie opuholi podjeludochnoy jelezyi: diagnostika i lechenie [Pancreatic cystic tumors: Diagnosis and management.]. Мoscow: Vidar-М, 2013. 328 p. (In Russian)

16. Cherdantsev D.V., Pervova O.V., Noskov I.G., Fokin D.V., Kazadaeva A.A., Kazadaeva I.A. Diagnostics of postnecrotic pancreatic cysts (review of literature). Grekov’s Bulletin of Surgery. 2020; 179 (2): 68–72. https://doi.org/10.24884/0042-4625-2020-179-2-68-72 (In Russian)

17. Wang X., Hu J., Yang F., Sun S. Needle-based confocal laser endomicroscopy for diagnosis of pancreatic cystic lesions: a meta-analysis. Minim. Invasive Ther. Allied Technol. 2022; 31 (5): 653–663. https://doi.org/10.1080/13645706.2021.1888750

18. Puşcaşu C.I., Rimbaş M., Mateescu R.B., Larghi A., Cauni V. Advances in the diagnosis of pancreatic cystic lesions. Diagnostics (Basel). 2022; 12 (8): 1779. https://doi.org/10.3390/diagnostics12081779.